Emergence and risk factors of β-lactamase-mediated resistance to oxyimino-β-lactams in Enterobacteriaceae isolates

Diagnostic Microbiology and Infectious Disease

Volumn 72, Issue 3, 2012, Pages 272-277

  Manageiro, Vera ^a   Ferreira, Eugénia ^a   Jones Dias, Daniela ^a   Louro, Deolinda ^a   Pinto, Margarida ^b,c   Diogo, José ^b   Caniça, Manuela ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b HOSPITAL GARCIA DE ORTA   (Portugal)

^c Universidade de Lisboa   (Portugal)

Author keywords

CTX M 15; CTX M 3; Enterobacteriaceae; ESBL; Oxyimino lactams; Portugal

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE CMY 2; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 1; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 3; BETA LACTAMASE CTX M 32; BETA LACTAMASE CTX M 9; BETA LACTAMASE DHA 1; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BETA LACTAMASE GES GENE; BETA LACTAMASE SHV GENE; BETA LACTAMASE TEM GENE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENZYME ANALYSIS; ENZYME SYNTHESIS; FEMALE; HOSPITAL INFECTION; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CHILD; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84856615690     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.11.009     Document Type: Article

References (26)

1. Ben-Ami R., Rodríguez-Baño J., Arslan H., Pitout J.D., Quentin C., Calbo E.S., Azap O.K., Arpin C., Pascual A., Livermore D.M., Garau J., Carmeli Y. A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin. Infect. Dis. 2009, 49:682-690.
2. Cantón R., Coque T.M. The CTX-M β-lactamase pandemic. Curr. Opin. Microbiol. 2006, 9:466-475.
3. Chen Y.T., Lauderdale T.L., Liao T.L., Shiau Y.R., Shu H.Y., Wu K.M., Yan J.J., Su I.J., Tsai S.F. Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 β-lactamases in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2007, 51:3004-3007.
4. Dutour C., Bonnet R., Marchandin H., Boyer M., Chanal C., Sirot D., Sirot J. CTX-M-1, CTX-M-3, and CTX-M-14 β-lactamases from Enterobacteriaceae isolated in France. Antimicrob. Agents Chemother. 2002, 46:534-537.
5. Empel J., Baraniak A., Literacka E., Mrówka A., Fiett J., Sadowy E., Hryniewicz W., Gniadkowski M. Molecular survey of β-lactamases conferring resistance to newer β-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob. Agents Chemother. 2008, 52:2449-2454. Beta-PL Study Group.
6. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 1988, 16:128-140.
7. Gniadkowski M., Schneider I., Pałucha A., Jungwirth R., Mikiewicz B., Bauernfeind A. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing β-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob. Agents Chemother. 1998, 42:827-832.
8. Hanson N.D. AmpC β-lactamases: what do we need to know for the future?. J. Antimicrob. Chemother. 2003, 52:2-4.
9. Hawkey P.M., Jones A.M. The changing epidemiology of resistance. J. Antimicrob. Chemother. 2009, 64:i3-10.
10. Jacoby G.A., Munoz-Price L.S. The new β-lactamases. N. Engl. J. Med. 2005, 352:380-391.
11. Lavigne J.P., Marchandin H., Delmas J., Moreau J., Bouziges N., Lecaillon E., Cavalie L., Jean-Pierre H., Bonnet R., Sotto A. CTX-M β-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors. J. Clin. Microbiol. 2007, 45:620-626.
12. CTX-M-15) genetic structures. Antimicrob. Agents Chemother. 2009, 53:1630-1635.
13. Livermore D.M., Canton R., Gniadkowski M., Nordmann P., Rossolini G.M., Arlet G., Ayala J., Coque T.M., Kern-Zdanowicz I., Luzzaro F., Poirel L., Woodford N. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 2007, 59:165-174.
14. Mendonça N., Ferreira E., Caniça M. Occurrence of a novel SHV-type enzyme (SHV-55) among isolates of Klebsiella pneumoniae from Portuguese origin in a comparison study for extended-spectrum beta-lactamase-producing evaluation. Diagn. Microbiol. Infect. Dis. 2006, 56:415-420.
15. Mendonça N., Leitão J., Manageiro V., Ferreira E., Caniça M. Spread of extended-spectrum β-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob. Agents Chemother. 2007, 51:1946-1955.
16. Mendonça N., Ferreira E., Louro D., Caniça M., ARSIP Participants Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum β-lactamase-producing Klebsiella pneumoniae isolated in Portugal. Int. J. Antimicrob. Agents 2009, 34:29-37.
17. Moriguchi N., Itahashi Y., Tabata N., Yamazumi T., Furuta I., Shibata N., Arakawa Y., Miyata H. Outbreak of CTX-M-3-type extended-spectrum β-lactamase-producing Enterobacter cloacae in a pediatric ward. J. Infect. Chemother. 2007, 13:263-266.
18. Nicolas-Chanoine M.H., Blanco J., Leflon-Guibout V., Demarty R., Alonso M.P., Caniça M.M., Park Y.J., Lavigne J.P., Pitout J., Johnson J.R. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 2008, 61:273-281.
19. Novais A., Comas I., Baquero F., Cantón R., Coque T.M., Moya A., González-Candelas F., Galán J.C. Evolutionary trajectories of β-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance. PLoS Pathog 2010, e1000735:6.
20. Pai H., Kang C.I., Byeon J.H., Lee K.D., Park W.B., Kim H.B., Kim E.C., Oh M.D., Choe K.W. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-β-lactamase-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2004, 48:3720-3728.
21. Pérez-Pérez F.J., Hanson N.D. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 2002, 40:2153-2162.
22. Pitout J.D., Nordmann P., Laupland K.B., Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 2005, 56:52-59.
23. Ramdani-Bouguessa N., Mendonça N., Leitão J., Ferreira E., Tazir M., Caniça M. CTX-M-3 and CTX-M-15 extended-spectrum β-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria. J. Clin. Microbiol. 2006, 44:4584-4586.
24. Sullivan K.M., Dean A., Soe M.M. OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Rep. 2009, 124:471-474.
25. Woodford N., Carattoli A., Karisik E., Underwood A., Ellington M.J., Livermore D.M. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob. Agents Chemother. 2009, 53:4472-4482.
26. Yan J.J., Ko W.C., Tsai S.H., Wu H.M., Jin Y.T., Wu J.J. Dissemination of CTX-M-3 and CMY-2 β-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J. Clin. Microbiol. 2000, 38:4320-4325.